| DC Field | Value | Language |
|---|
| dc.contributor.author | Kuzubova, E. V. | - |
| dc.contributor.author | Radchenko, A. I. | - |
| dc.contributor.author | Korokina, A. M. | - |
| dc.contributor.author | Koroleva, N. V. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.date.accessioned | 2025-10-27T09:23:19Z | - |
| dc.date.available | 2025-10-27T09:23:19Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Assessment of physiological parameters in the application of a double adeno-associated virus 9 with a codon-optimized DYSF gene for limb girdle muscular dystrophy type R2 / E.V. Kuzubova, A.I. Radchenko, A.M. Korokina [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №2.-P. 36-47. - Doi: 10.18413/rrpharmacology.11.642. - Refer.: p. 45-46. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65477 | - |
| dc.description.abstract | The aim of this study was to study the efficacy and safety of the use of a genetic construct, the AAV9-DYSF-DV3’ virus, for the treatment of limb girdle muscular dystrophy LGMD) type R2 | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | dysferlin | ru |
| dc.subject | LGMD R2 | ru |
| dc.subject | dual AAV vector | ru |
| dc.subject | gene transfer | ru |
| dc.subject | muscle regeneration | ru |
| dc.subject | adeno-associated virus 9 | ru |
| dc.subject | muscular dystrophy | ru |
| dc.title | Assessment of physiological parameters in the application of a double adeno-associated virus 9 with a codon-optimized DYSF gene for limb girdle muscular dystrophy type R2 | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 2
|
